Sign In

Dr. Sally Ann Newbrough M.D.

Allergy & Immunology Physician

/

Allergy & Immunology Physician

Phone, Open Hours, Reviews & Information

4011 172nd Street Northeast, Arlington, Washington 98223, United States
Spoken Languages: Castilian, English, Spanish
Gender: Female

 

Pharmacy Blue Star Customer Rating Customer Ratings

More practice addresses of Sally Ann Newbrough

9709 3rd Avenue Northeast, Seattle, Washington 98115, United States

(206) 860-4454

Reviews about Sally Ann Newbrough

No reviews. Be first - Add your review about Dr. Sally Ann Newbrough M.D.

Log in or sign up to post new review

A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.

An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.

Source: NUCC, CMS

Health Insurance Plans Sally Ann Newbrough accepts

Issuer Network State Plan Year New Patients Last Updated
Premera Blue Cross Blue Shield of Alaska LEGACYANDDENTALSELECT AK 2025 accepting Oct 10 2024
PacificSource Health Plans TIER-ONE MT 2025 accepting Oct 21 2024
PacificSource Health Plans TIER-TWO OR 2025 accepting Oct 21 2024

Source: CMS.gov, HealthPorta API